PubRank

Jason P Eiserich

Author PubWeight™ 47.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003 4.36
2 Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci U S A 2005 4.07
3 Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett 2005 2.13
4 Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci U S A 2006 1.95
5 Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A 2004 1.87
6 Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP. J Biol Chem 2001 1.61
7 Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity. Proc Natl Acad Sci U S A 2002 1.59
8 Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. Free Radic Biol Med 2002 1.40
9 Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 2006 1.35
10 The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol 2004 1.20
11 Normal and prostate cancer cells display distinct molecular profiles of alpha-tubulin posttranslational modifications. Prostate 2006 1.17
12 Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med 2004 1.16
13 Sepsis and hypotension: enter kynurenine, move over nitric oxide. Crit Care Med 2011 1.13
14 Cytochrome c: a catalyst and target of nitrite-hydrogen peroxide-dependent protein nitration. Arch Biochem Biophys 2004 1.08
15 Characteristics and effects of inflammation in end-stage renal disease. Semin Dial 2003 1.03
16 Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients. Free Radic Biol Med 2012 1.00
17 Duox2 exhibits potent heme peroxidase activity in human respiratory tract epithelium. FEBS Lett 2006 0.98
18 Alteration of the C-terminal amino acid of tubulin specifically inhibits myogenic differentiation. J Biol Chem 2002 0.98
19 Role of aging versus the loss of estrogens in the reduction in vascular function in female rats. Endocrinology 2008 0.98
20 Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions. Hepatology 2003 0.97
21 Inhibition of oral peroxidase activity by cigarette smoke: in vivo and in vitro studies. Free Radic Biol Med 2003 0.93
22 Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease. Clin Chim Acta 2008 0.92
23 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology 2004 0.90
24 Posttranslational nitrotyrosination of alpha-tubulin induces cell cycle arrest and inhibits proliferation of vascular smooth muscle cells. Eur J Cell Biol 2006 0.89
25 Induction of motor neuron apoptosis by free 3-nitro-L-tyrosine. J Neurochem 2004 0.88
26 Modulation of arachidonic and linoleic acid metabolites in myeloperoxidase-deficient mice during acute inflammation. Free Radic Biol Med 2010 0.85
27 Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J Nutr 2003 0.85
28 Cytokine induction of prolactin receptors mediates prolactin inhibition of nitric oxide synthesis in pulmonary fibroblasts. FEBS Lett 2003 0.85
29 17beta-Estradiol reverses shear-stress-mediated low density lipoprotein modifications. Free Radic Biol Med 2006 0.85
30 A reappraisal of the genomic organization of human Nox1 and its splice variants. Arch Biochem Biophys 2005 0.84
31 Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase. Free Radic Res 2010 0.82
32 Differentiation of the roles of NO from airway epithelium and inflammatory cells in ozone-induced lung inflammation. Toxicol Appl Pharmacol 2006 0.81
33 The potentiation of myeloperoxidase activity by the glycosaminoglycan-dependent binding of myeloperoxidase to proteins of the extracellular matrix. Biochim Biophys Acta 2013 0.81
34 Apolipoprotein E3- and nitric oxide-dependent modulation of endothelial cell inflammatory responses. Arterioscler Thromb Vasc Biol 2006 0.79
35 Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway. J Cyst Fibros 2010 0.78
36 Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients. Blood Purif 2006 0.77
37 Are Drosophila a useful model for understanding the toxicity of inhaled oxidative pollutants: a review. Inhal Toxicol 2005 0.77
38 Compromised aortic vasoreactivity in male estrogen receptor-alpha-deficient mice during acute lipopolysaccharide-induced inflammation. Endocrinology 2006 0.76
39 Oxidative stress in acute lung injury: Déjà vu or something new? Crit Care Med 2004 0.75
40 Nebulized nitric oxide/nucleophile adduct: Donating nitric oxide to the lung. Crit Care Med 2005 0.75
41 Oxidized plasma high-density lipoprotein is decreased in Alzheimer's disease. Free Radic Biol Med 2006 0.75